Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients in Gout (Pharm-UP) Study
This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.
• US Veterans with physician-diagnosed
• Documented hyperuricemia (SU \> 6.8 milligrams per deciliter)
• Satisfy American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) gout classification criteria
• Report 1 or more flares in the prior 6 months
• Receipt of a new urate-lowering therapy (ULT) prescription (allopurinol or febuxostat) initiated by a primary care provider or longer term ULT but otherwise satisfy the flare/SU criteria